跳至主要内容
临床试验/NCT07813182
NCT07813182尚未招募不适用

Efficacy and Safety of Saccharomyces Boulardii in Treatment of Acute Diarrhea in Children Aged 6 Months to 5 Years Old

Can Tho University of Medicine and Pharmacy1 个研究点 分布在 1 个国家目标入组 206 人开始时间: 2026年8月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
入组人数
206
试验地点
1
主要终点
Duration of diarrhea

研究概览

简要总结

This study aimed to evaluate the effectiveness of saccharomyces-based treatment in children with acute diarrhea aged 6 months to 5 years compared to children treated with standard methods.

详细描述

A total of 206 children diagnosed with acute diarrhea will be evaluated and divided into two groups based on a random distribution list: Group A and Group B.

Group A will be treated with standard methods including fluid replacement and zinc according to the Ministry of Health's protocol.

Group B will be treated similarly to Group A, but with the addition of Saccharomyces boulardii at a dose of 250 to 750 mg per day until discharge.

Both groups of children will receive the same counseling and monitoring, with guidance provided to parents.

Caregivers are advised to record symptoms and stool diaries daily.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

The blinding method was not performed.

入排标准

年龄范围
6 Months 至 60 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age from 6 months to 5 years old
  • Children are diagnosed with acute diarrhea according to WHO criteria.

排除标准

  • Bloody, mucous stools.
  • Signs of sepsis requiring admission to the Intensive Care Unit.
  • Currently suffering from chronic diseases such as cow's milk protein allergy, nephrotic syndrome, immunodeficiency, and systemic diseases.
  • Currently using immunosuppressant drugs.

研究组 & 干预措施

Saccharomyces boulardii

Experimental

Saccharomyces boulardii is a type of yeast that helps to quickly restore the intestinal mucosal barrier and the gut microbiome, significantly shortening hospital stays.

干预措施: Saccharomyces Boulardii Probiotic Supplement (Drug)

Standard treatment includes fluid replacement and zinc supplementation.

Active Comparator

Treatment should follow standard protocols with fluid replacement and zinc supplementation, but no additional Saccharomyces boulardii should be added until discharge.

干预措施: The child will be treated with standard method (Drug)

结局指标

主要结局

Duration of diarrhea

时间窗: Immediately after the intervention

The cessation of acute diarrhea is determined when children met following criteria: 1. Passing soft or formed stools twice in a row. 2. No bowel movements recorded for 12 consecutive hours. 3. Stool consistency returns to normal, corresponding to categories 3 to 5 on the Bristol stool scale.

The frequency of stool

时间窗: At day 1, 3, 5

Total number of bowel movements per day

Stool consistency assessed by Bristol stool chart

时间窗: At day 1, 3, 5

The Bristol stool chart has 7 pictures of stool appearance. The number 1 mean hard stool and number 7 mean watery stool.

次要结局

  • Cost effectiveness(Immediately after the intervention)
  • Length of hospitalization(Immediately after the intervention)
  • Adverse events(Immediately after the intervention)
  • Rate of Hospital readmission(At day 14 and 28 after discharge from the hospital.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nguyễn Thị Phương Thão

Principal Investigator

Can Tho University of Medicine and Pharmacy

研究点 (1)

Loading locations...

相似试验